Merck’s new covid pill linked to virus mutations, study finds

 Merck & Co.'s new anti-viral covid drug Lagevrio (molnupiravir) is triggering the formation of new "strains" of the disease. The fact that mutations are happening at all, rather than the miracle cure that Merck claimed would happen, is concerning.

Merck denies problems with molnupiravir

• Spokesman Robert Josephson told the media that there is "no evidence to indicate that any antiviral agent has contributed to the emergence of circulating variants."
• Merck is a solution, not the problem, to all new variants.
• The U.S. Food and Drug Administration (FDA), which first approved Lagevrio in late 2021, is refusing to comment on the new research because it came from a third party.

https://www.naturalnews.com/2023-02-02-merck-covid-pill-new-virus-mutations-study.html